Stago offers a comprehensive range for anticoagulant monitoring: The STA®-Liquid Anti-Xa is a specific, easy to use and reliable test. Fully automated test on STA® line analysers, it is the solution of choice for UFH, LMWH, Fondaparinux, Rivaroxaban and Apixaban monitoring. STA ECA II -Ecarin Chromogenic Assay for direct thrombin inhibitors (Dabigatran) VKA- Prothrombin range (STA NeoPTimal and STA Neoplastin R) HITs testing- screening tests and ELISA assays.
Heparins (UFH and LMWH) and Direct Anti-Xa Oral Anticoagulants are used for the prevention and treatment of thromboembolic diseases.
STA Liquid Anti Xa assay
The quantitative determination of anti-Xa activity:
> of the Heparin (UFH and LMWH) is helpful for monitoring treatment efficacy
> of Rivaroxaban, Apixaban or Edoxaban level, in conjunction with clinical examination, is helpful in the assessment of the clinical status in certain situations.
Ecarin chromogenic assay of direct thrombin inhibitors (dabigatran)
ECA II Assay
Improvement of Ecarin Clotting Time
Not sensitive to factor II and fibrinogen levels
Standardized and fully automated
STA – ECA II
STA – Dabigatran Calibrator
STA – Dabigatran Control
Heparin Induced Thrombocytopenia
Heparin induced thrombocytopenia type II (HIT) is a life-threatening disease associated with exposure to unfractionated or less commonly low-molecular-weight heparin. HIT occurs in up to 5 % of patients on heparin.
Lateral Flow Immunoassay to detect IgG antibodies against heparin-PF 4 complexes
Determination of anti-heparin PF4 antibodies of IgG class by ELISA method
Asserachrom HPIA- Polyspecific
Determination of anti-heparin PF4 antibodies by ELISA method (IgG, IgM& IgA)